||Family health history and health risk assessment for cardiovascular disease in health care -- Personalized lifestyle medicine -- Lipoprotein disorders -- Metabolic syndrome -- Hypertension -- Novel approaches to cardiovascular diagnostics : focus on coronary artery disease and myocardial infarction -- Hypertrophic cardiomyopathy in the era of genomic medicine -- Genomics to predict risk of coronary artery disease -- Genomics-guided antithrombotic therapy for acute coronary syndromes -- Heart failure : impact of genetics and genomics -- Arrhythmia genomics -- Genetics and genomics of peripheral arterial disease -- Genetic basis of congenital heart disease -- Perioperative genomics -- Genomics of ischemic stroke and prospects for clinical applications -- Cardiovascular pharmacogenetics.
||Genomic and Precision Medicine: Cardiovascular Disease, Third Edition, focuses on the applications of genome discovery on the broad spectrum of cardiovascular disorders. Each chapter is organized for the application of genomics and personalized medicine tools and technologies to a) Risk Assessment and Susceptibility, b) Diagnosis and Prognosis, c) Pharmacogenomics and Precision Therapeutics, and d) Emerging and Future Opportunities in the field.
|General note||Title for previous editions: Genomic and personalized medicine.|
|General note||Revised edition of: Genomic and personalized medicine / edited by Geoffrey S. Ginsburg and Huntington F. Willard. 2nd ed. 2013.|
|Bibliography note||Includes bibliographical references.|
|Source of description||Online resource; title from electronic title page (ClinicalKey, viewed November 14, 2017).|
|Issued in other form||Print version: Genomic and personalized medicine : cardiovascular disease. London : Academic Press is an imprint of Elsevier,  9780128018125|
||Preceded by: Genomic and personalized medicine. 2nd ed. 2013.
|ISBN||9780128018255 (electronic bk.)|
|ISBN||0128018259 (electronic bk.)|